Logo image of ACR

ACRES COMMERCIAL REALTY CORP (ACR) Stock Fundamental Analysis

NYSE:ACR - New York Stock Exchange, Inc. - US00489Q1022 - REIT - Currency: USD

21.13  +0.37 (+1.78%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to ACR. ACR was compared to 64 industry peers in the Mortgage Real Estate Investment Trusts (REITs)" industry. ACR has a bad profitability rating. Also its financial health evaluation is rather negative. ACR is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

ACR had positive earnings in the past year.
In the past year ACR had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: ACR reported negative net income in multiple years.
Of the past 5 years ACR 4 years had a positive operating cash flow.
ACR Yearly Net Income VS EBIT VS OCF VS FCFACR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M -100M 200M -200M

1.2 Ratios

ACR has a Return On Assets of 0.33%. This is comparable to the rest of the industry: ACR outperforms 40.63% of its industry peers.
ACR's Return On Equity of 1.54% is in line compared to the rest of the industry. ACR outperforms 40.63% of its industry peers.
ACR has a Return On Invested Capital (0.66%) which is comparable to the rest of the industry.
ACR had an Average Return On Invested Capital over the past 3 years of 0.83%. This is in line with the industry average of 1.76%.
Industry RankSector Rank
ROA 0.33%
ROE 1.54%
ROIC 0.66%
ROA(3y)0.18%
ROA(5y)-2.2%
ROE(3y)0.89%
ROE(5y)-10.99%
ROIC(3y)0.83%
ROIC(5y)N/A
ACR Yearly ROA, ROE, ROICACR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -20 -40 -60

1.3 Margins

Looking at the Profit Margin, with a value of 3.23%, ACR is doing worse than 60.94% of the companies in the same industry.
In the last couple of years the Profit Margin of ACR has declined.
With a Operating Margin value of 7.48%, ACR perfoms like the industry average, outperforming 42.19% of the companies in the same industry.
In the last couple of years the Operating Margin of ACR has declined.
The Gross Margin of ACR (37.42%) is better than 71.88% of its industry peers.
ACR's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 7.48%
PM (TTM) 3.23%
GM 37.42%
OM growth 3Y-66.32%
OM growth 5Y-18.9%
PM growth 3Y-82.86%
PM growth 5Y-25.09%
GM growth 3Y-40.82%
GM growth 5Y0.82%
ACR Yearly Profit, Operating, Gross MarginsACR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100 200

More info and screens

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ACR is destroying value.
ACR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ACR Yearly Shares OutstandingACR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M
ACR Yearly Total Debt VS Total AssetsACR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B 2B 2.5B

2.2 Solvency

ACR has an Altman-Z score of -0.35. This is a bad value and indicates that ACR is not financially healthy and even has some risk of bankruptcy.
ACR has a Altman-Z score of -0.35. This is comparable to the rest of the industry: ACR outperforms 40.63% of its industry peers.
A Debt/Equity ratio of 3.25 is on the high side and indicates that ACR has dependencies on debt financing.
ACR has a Debt to Equity ratio of 3.25. This is in the better half of the industry: ACR outperforms 68.75% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.25
Debt/FCF N/A
Altman-Z -0.35
ROIC/WACC0.1
WACC6.41%
ACR Yearly LT Debt VS Equity VS FCFACR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 0.58 indicates that ACR may have some problems paying its short term obligations.
ACR has a better Current ratio (0.58) than 71.88% of its industry peers.
A Quick Ratio of 0.58 indicates that ACR may have some problems paying its short term obligations.
ACR has a better Quick ratio (0.58) than 71.88% of its industry peers.
Industry RankSector Rank
Current Ratio 0.58
Quick Ratio 0.58
ACR Yearly Current Assets VS Current LiabilitesACR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for ACR have decreased strongly by -42.08% in the last year.
ACR shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -15.41% yearly.
EPS 1Y (TTM)-42.08%
EPS 3YN/A
EPS 5Y-15.41%
EPS Q2Q%-12.73%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-61.68%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y35.88%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-1.47%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ACR Yearly Revenue VS EstimatesACR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M
ACR Yearly EPS VS EstimatesACR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2 -2 4 -4

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 15.20 indicates a correct valuation of ACR.
Compared to the rest of the industry, the Price/Earnings ratio of ACR is on the same level as its industry peers.
ACR's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 29.35.
With a Price/Forward Earnings ratio of 11.19, the valuation of ACR can be described as very reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ACR is on the same level as its industry peers.
ACR is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.10, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 15.2
Fwd PE 11.19
ACR Price Earnings VS Forward Price EarningsACR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ACR indicates a rather cheap valuation: ACR is cheaper than 82.81% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 72.01
ACR Per share dataACR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40 50

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.42
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ACR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ACRES COMMERCIAL REALTY CORP

NYSE:ACR (3/7/2025, 8:04:00 PM)

21.13

+0.37 (+1.78%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryMortgage Real Estate Investment Trusts (REITs)"
Earnings (Last)03-05 2025-03-05/amc
Earnings (Next)07-29 2025-07-29/amc
Inst Owners36.3%
Inst Owner Change7.13%
Ins Owners3.32%
Ins Owner Change0%
Market Cap163.55M
Analysts77.14
Price Target19.89 (-5.87%)
Short Float %0.14%
Short Ratio0.38
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend2.34
Dividend Growth(5Y)-1.24%
DP287.13%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-14.91%
Min EPS beat(2)-39.59%
Max EPS beat(2)9.77%
EPS beat(4)2
Avg EPS beat(4)-20.18%
Min EPS beat(4)-65.56%
Max EPS beat(4)14.64%
EPS beat(8)6
Avg EPS beat(8)6.71%
EPS beat(12)9
Avg EPS beat(12)6.7%
EPS beat(16)10
Avg EPS beat(16)-19.3%
Revenue beat(2)1
Avg Revenue beat(2)1.5%
Min Revenue beat(2)-1.99%
Max Revenue beat(2)4.99%
Revenue beat(4)2
Avg Revenue beat(4)0.65%
Min Revenue beat(4)-13.77%
Max Revenue beat(4)13.38%
Revenue beat(8)6
Avg Revenue beat(8)29.91%
Revenue beat(12)10
Avg Revenue beat(12)66%
Revenue beat(16)14
Avg Revenue beat(16)88.88%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-8.19%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.79%
Valuation
Industry RankSector Rank
PE 15.2
Fwd PE 11.19
P/S 0.79
P/FCF N/A
P/OCF 5.84
P/B 0.37
P/tB 0.38
EV/EBITDA 72.01
EPS(TTM)1.39
EY6.58%
EPS(NY)1.89
Fwd EY8.94%
FCF(TTM)-3.3
FCFYN/A
OCF(TTM)3.62
OCFY17.13%
SpS26.92
BVpS56.37
TBVpS55.45
PEG (NY)0.42
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.33%
ROE 1.54%
ROCE 0.84%
ROIC 0.66%
ROICexc 0.69%
ROICexgc 0.69%
OM 7.48%
PM (TTM) 3.23%
GM 37.42%
FCFM N/A
ROA(3y)0.18%
ROA(5y)-2.2%
ROE(3y)0.89%
ROE(5y)-10.99%
ROIC(3y)0.83%
ROIC(5y)N/A
ROICexc(3y)0.86%
ROICexc(5y)N/A
ROICexgc(3y)0.86%
ROICexgc(5y)N/A
ROCE(3y)1.06%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-8.89%
ROICexc growth 3YN/A
ROICexc growth 5Y-8.94%
OM growth 3Y-66.32%
OM growth 5Y-18.9%
PM growth 3Y-82.86%
PM growth 5Y-25.09%
GM growth 3Y-40.82%
GM growth 5Y0.82%
F-Score7
Asset Turnover0.1
Health
Industry RankSector Rank
Debt/Equity 3.25
Debt/FCF N/A
Debt/EBITDA 64.43
Cap/Depr 836.92%
Cap/Sales 25.69%
Interest Coverage 0.13
Cash Conversion 127.45%
Profit Quality N/A
Current Ratio 0.58
Quick Ratio 0.58
Altman-Z -0.35
F-Score7
WACC6.41%
ROIC/WACC0.1
Cap/Depr(3y)612.45%
Cap/Depr(5y)N/A
Cap/Sales(3y)23.21%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-42.08%
EPS 3YN/A
EPS 5Y-15.41%
EPS Q2Q%-12.73%
EPS Next Y35.88%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-61.68%
Revenue Next Year-1.47%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y38.62%
EBIT growth 3YN/A
EBIT growth 5Y-8.82%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y38.31%
FCF growth 3Y-38.44%
FCF growth 5Y-31.22%
OCF growth 1Y-17.85%
OCF growth 3Y12.77%
OCF growth 5Y-1.1%